世界の早産治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Premature Labor Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z4769
• 出版社/出版日：QYResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、93ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査資料では、早産治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（プロゲステロン、OBE-022、レトシバン、その他）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・早産治療の市場動向
・企業の競争状況、市場シェア
・早産治療の種類別市場規模（プロゲステロン、OBE-022、レトシバン、その他）
・早産治療の用途別市場規模（病院、診療所、その他）
・早産治療の北米市場規模2016-2027（アメリカ、カナダ）
・早産治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・早産治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・早産治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・早産治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（AMAG Pharmaceuticals Inc、GlaxoSmithKline Plc、Juniper Pharmaceuticals Inc、Kissei Pharmaceutical Co Ltd、Lipocine Inc、ObsEva SA）
・結論

Market Analysis and Insights: Global Premature Labor Treatment Market
The global Premature Labor Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Premature Labor Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Premature Labor Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Premature Labor Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Premature Labor Treatment market.

Global Premature Labor Treatment Scope and Market Size
Premature Labor Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Premature Labor Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Progesterone
OBE-022
Retosiban
Others

Segment by Application
Hospital
Clinic
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
AMAG Pharmaceuticals Inc
GlaxoSmithKline Plc
Juniper Pharmaceuticals Inc
Kissei Pharmaceutical Co Ltd
Lipocine Inc
ObsEva SA

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Premature Labor Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Progesterone
1.2.3 OBE-022
1.2.4 Retosiban
1.2.5 Others
1.3 Market by Application
1.3.1 Global Premature Labor Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Premature Labor Treatment Market Perspective (2016-2027)
2.2 Premature Labor Treatment Growth Trends by Regions
2.2.1 Premature Labor Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Premature Labor Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Premature Labor Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Premature Labor Treatment Industry Dynamic
2.3.1 Premature Labor Treatment Market Trends
2.3.2 Premature Labor Treatment Market Drivers
2.3.3 Premature Labor Treatment Market Challenges
2.3.4 Premature Labor Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Premature Labor Treatment Players by Revenue
3.1.1 Global Top Premature Labor Treatment Players by Revenue (2016-2021)
3.1.2 Global Premature Labor Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Premature Labor Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Premature Labor Treatment Revenue
3.4 Global Premature Labor Treatment Market Concentration Ratio
3.4.1 Global Premature Labor Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Premature Labor Treatment Revenue in 2020
3.5 Premature Labor Treatment Key Players Head office and Area Served
3.6 Key Players Premature Labor Treatment Product Solution and Service
3.7 Date of Enter into Premature Labor Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Premature Labor Treatment Breakdown Data by Type
4.1 Global Premature Labor Treatment Historic Market Size by Type (2016-2021)
4.2 Global Premature Labor Treatment Forecasted Market Size by Type (2022-2027)

5 Premature Labor Treatment Breakdown Data by Application
5.1 Global Premature Labor Treatment Historic Market Size by Application (2016-2021)
5.2 Global Premature Labor Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Premature Labor Treatment Market Size (2016-2027)
6.2 North America Premature Labor Treatment Market Size by Type
6.2.1 North America Premature Labor Treatment Market Size by Type (2016-2021)
6.2.2 North America Premature Labor Treatment Market Size by Type (2022-2027)
6.2.3 North America Premature Labor Treatment Market Size by Type (2016-2027)
6.3 North America Premature Labor Treatment Market Size by Application
6.3.1 North America Premature Labor Treatment Market Size by Application (2016-2021)
6.3.2 North America Premature Labor Treatment Market Size by Application (2022-2027)
6.3.3 North America Premature Labor Treatment Market Size by Application (2016-2027)
6.4 North America Premature Labor Treatment Market Size by Country
6.4.1 North America Premature Labor Treatment Market Size by Country (2016-2021)
6.4.2 North America Premature Labor Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Premature Labor Treatment Market Size (2016-2027)
7.2 Europe Premature Labor Treatment Market Size by Type
7.2.1 Europe Premature Labor Treatment Market Size by Type (2016-2021)
7.2.2 Europe Premature Labor Treatment Market Size by Type (2022-2027)
7.2.3 Europe Premature Labor Treatment Market Size by Type (2016-2027)
7.3 Europe Premature Labor Treatment Market Size by Application
7.3.1 Europe Premature Labor Treatment Market Size by Application (2016-2021)
7.3.2 Europe Premature Labor Treatment Market Size by Application (2022-2027)
7.3.3 Europe Premature Labor Treatment Market Size by Application (2016-2027)
7.4 Europe Premature Labor Treatment Market Size by Country
7.4.1 Europe Premature Labor Treatment Market Size by Country (2016-2021)
7.4.2 Europe Premature Labor Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Premature Labor Treatment Market Size (2016-2027)
8.2 Asia-Pacific Premature Labor Treatment Market Size by Type
8.2.1 Asia-Pacific Premature Labor Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Premature Labor Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Premature Labor Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Premature Labor Treatment Market Size by Application
8.3.1 Asia-Pacific Premature Labor Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Premature Labor Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Premature Labor Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Premature Labor Treatment Market Size by Region
8.4.1 Asia-Pacific Premature Labor Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Premature Labor Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Premature Labor Treatment Market Size (2016-2027)
9.2 Latin America Premature Labor Treatment Market Size by Type
9.2.1 Latin America Premature Labor Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Premature Labor Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Premature Labor Treatment Market Size by Type (2016-2027)
9.3 Latin America Premature Labor Treatment Market Size by Application
9.3.1 Latin America Premature Labor Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Premature Labor Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Premature Labor Treatment Market Size by Application (2016-2027)
9.4 Latin America Premature Labor Treatment Market Size by Country
9.4.1 Latin America Premature Labor Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Premature Labor Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Premature Labor Treatment Market Size (2016-2027)
10.2 Middle East & Africa Premature Labor Treatment Market Size by Type
10.2.1 Middle East & Africa Premature Labor Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Premature Labor Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Premature Labor Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Premature Labor Treatment Market Size by Application
10.3.1 Middle East & Africa Premature Labor Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Premature Labor Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Premature Labor Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Premature Labor Treatment Market Size by Country
10.4.1 Middle East & Africa Premature Labor Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Premature Labor Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 AMAG Pharmaceuticals Inc
11.1.1 AMAG Pharmaceuticals Inc Company Details
11.1.2 AMAG Pharmaceuticals Inc Business Overview
11.1.3 AMAG Pharmaceuticals Inc Premature Labor Treatment Introduction
11.1.4 AMAG Pharmaceuticals Inc Revenue in Premature Labor Treatment Business (2016-2021)
11.1.5 AMAG Pharmaceuticals Inc Recent Development
11.2 GlaxoSmithKline Plc
11.2.1 GlaxoSmithKline Plc Company Details
11.2.2 GlaxoSmithKline Plc Business Overview
11.2.3 GlaxoSmithKline Plc Premature Labor Treatment Introduction
11.2.4 GlaxoSmithKline Plc Revenue in Premature Labor Treatment Business (2016-2021)
11.2.5 GlaxoSmithKline Plc Recent Development
11.3 Juniper Pharmaceuticals Inc
11.3.1 Juniper Pharmaceuticals Inc Company Details
11.3.2 Juniper Pharmaceuticals Inc Business Overview
11.3.3 Juniper Pharmaceuticals Inc Premature Labor Treatment Introduction
11.3.4 Juniper Pharmaceuticals Inc Revenue in Premature Labor Treatment Business (2016-2021)
11.3.5 Juniper Pharmaceuticals Inc Recent Development
11.4 Kissei Pharmaceutical Co Ltd
11.4.1 Kissei Pharmaceutical Co Ltd Company Details
11.4.2 Kissei Pharmaceutical Co Ltd Business Overview
11.4.3 Kissei Pharmaceutical Co Ltd Premature Labor Treatment Introduction
11.4.4 Kissei Pharmaceutical Co Ltd Revenue in Premature Labor Treatment Business (2016-2021)
11.4.5 Kissei Pharmaceutical Co Ltd Recent Development
11.5 Lipocine Inc
11.5.1 Lipocine Inc Company Details
11.5.2 Lipocine Inc Business Overview
11.5.3 Lipocine Inc Premature Labor Treatment Introduction
11.5.4 Lipocine Inc Revenue in Premature Labor Treatment Business (2016-2021)
11.5.5 Lipocine Inc Recent Development
11.6 ObsEva SA
11.6.1 ObsEva SA Company Details
11.6.2 ObsEva SA Business Overview
11.6.3 ObsEva SA Premature Labor Treatment Introduction
11.6.4 ObsEva SA Revenue in Premature Labor Treatment Business (2016-2021)
11.6.5 ObsEva SA Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Premature Labor Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Progesterone
Table 3. Key Players of OBE-022
Table 4. Key Players of Retosiban
Table 5. Key Players of Others
Table 6. Global Premature Labor Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Premature Labor Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Premature Labor Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Premature Labor Treatment Market Share by Regions (2016-2021)
Table 10. Global Premature Labor Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Premature Labor Treatment Market Share by Regions (2022-2027)
Table 12. Premature Labor Treatment Market Trends
Table 13. Premature Labor Treatment Market Drivers
Table 14. Premature Labor Treatment Market Challenges
Table 15. Premature Labor Treatment Market Restraints
Table 16. Global Premature Labor Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Premature Labor Treatment Market Share by Players (2016-2021)
Table 18. Global Top Premature Labor Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Premature Labor Treatment as of 2020)
Table 19. Ranking of Global Top Premature Labor Treatment Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Premature Labor Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Premature Labor Treatment Product Solution and Service
Table 23. Date of Enter into Premature Labor Treatment Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Premature Labor Treatment Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Premature Labor Treatment Revenue Market Share by Type (2016-2021)
Table 27. Global Premature Labor Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Premature Labor Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Premature Labor Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Premature Labor Treatment Revenue Market Share by Application (2016-2021)
Table 31. Global Premature Labor Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Premature Labor Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Premature Labor Treatment Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Premature Labor Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Premature Labor Treatment Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Premature Labor Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Premature Labor Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Premature Labor Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Premature Labor Treatment Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Premature Labor Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Premature Labor Treatment Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Premature Labor Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Premature Labor Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Premature Labor Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Premature Labor Treatment Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Premature Labor Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Premature Labor Treatment Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Premature Labor Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Premature Labor Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Premature Labor Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Premature Labor Treatment Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Premature Labor Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Premature Labor Treatment Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Premature Labor Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Premature Labor Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Premature Labor Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Premature Labor Treatment Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Premature Labor Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Premature Labor Treatment Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Premature Labor Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Premature Labor Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Premature Labor Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 63. AMAG Pharmaceuticals Inc Company Details
Table 64. AMAG Pharmaceuticals Inc Business Overview
Table 65. AMAG Pharmaceuticals Inc Premature Labor Treatment Product
Table 66. AMAG Pharmaceuticals Inc Revenue in Premature Labor Treatment Business (2016-2021) & (US$ Million)
Table 67. AMAG Pharmaceuticals Inc Recent Development
Table 68. GlaxoSmithKline Plc Company Details
Table 69. GlaxoSmithKline Plc Business Overview
Table 70. GlaxoSmithKline Plc Premature Labor Treatment Product
Table 71. GlaxoSmithKline Plc Revenue in Premature Labor Treatment Business (2016-2021) & (US$ Million)
Table 72. GlaxoSmithKline Plc Recent Development
Table 73. Juniper Pharmaceuticals Inc Company Details
Table 74. Juniper Pharmaceuticals Inc Business Overview
Table 75. Juniper Pharmaceuticals Inc Premature Labor Treatment Product
Table 76. Juniper Pharmaceuticals Inc Revenue in Premature Labor Treatment Business (2016-2021) & (US$ Million)
Table 77. Juniper Pharmaceuticals Inc Recent Development
Table 78. Kissei Pharmaceutical Co Ltd Company Details
Table 79. Kissei Pharmaceutical Co Ltd Business Overview
Table 80. Kissei Pharmaceutical Co Ltd Premature Labor Treatment Product
Table 81. Kissei Pharmaceutical Co Ltd Revenue in Premature Labor Treatment Business (2016-2021) & (US$ Million)
Table 82. Kissei Pharmaceutical Co Ltd Recent Development
Table 83. Lipocine Inc Company Details
Table 84. Lipocine Inc Business Overview
Table 85. Lipocine Inc Premature Labor Treatment Product
Table 86. Lipocine Inc Revenue in Premature Labor Treatment Business (2016-2021) & (US$ Million)
Table 87. Lipocine Inc Recent Development
Table 88. ObsEva SA Company Details
Table 89. ObsEva SA Business Overview
Table 90. ObsEva SA Premature Labor Treatment Product
Table 91. ObsEva SA Revenue in Premature Labor Treatment Business (2016-2021) & (US$ Million)
Table 92. ObsEva SA Recent Development
Table 93. Research Programs/Design for This Report
Table 94. Key Data Information from Secondary Sources
Table 95. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Premature Labor Treatment Market Share by Type: 2020 VS 2027
Figure 2. Progesterone Features
Figure 3. OBE-022 Features
Figure 4. Retosiban Features
Figure 5. Others Features
Figure 6. Global Premature Labor Treatment Market Share by Application: 2020 VS 2027
Figure 7. Hospital Case Studies
Figure 8. Clinic Case Studies
Figure 9. Others Case Studies
Figure 10. Premature Labor Treatment Report Years Considered
Figure 11. Global Premature Labor Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Premature Labor Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Premature Labor Treatment Market Share by Regions: 2020 VS 2027
Figure 14. Global Premature Labor Treatment Market Share by Regions (2022-2027)
Figure 15. Global Premature Labor Treatment Market Share by Players in 2020
Figure 16. Global Top Premature Labor Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Premature Labor Treatment as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Premature Labor Treatment Revenue in 2020
Figure 18. Global Premature Labor Treatment Revenue Market Share by Type (2016-2021)
Figure 19. Global Premature Labor Treatment Revenue Market Share by Type (2022-2027)
Figure 20. North America Premature Labor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Premature Labor Treatment Market Share by Type (2016-2027)
Figure 22. North America Premature Labor Treatment Market Share by Application (2016-2027)
Figure 23. North America Premature Labor Treatment Market Share by Country (2016-2027)
Figure 24. United States Premature Labor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Premature Labor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Premature Labor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Premature Labor Treatment Market Share by Type (2016-2027)
Figure 28. Europe Premature Labor Treatment Market Share by Application (2016-2027)
Figure 29. Europe Premature Labor Treatment Market Share by Country (2016-2027)
Figure 30. Germany Premature Labor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Premature Labor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Premature Labor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Premature Labor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Premature Labor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Premature Labor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Premature Labor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Premature Labor Treatment Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Premature Labor Treatment Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Premature Labor Treatment Market Share by Region (2016-2027)
Figure 40. China Premature Labor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Premature Labor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Premature Labor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Premature Labor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Premature Labor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Premature Labor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Premature Labor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Premature Labor Treatment Market Share by Type (2016-2027)
Figure 48. Latin America Premature Labor Treatment Market Share by Application (2016-2027)
Figure 49. Latin America Premature Labor Treatment Market Share by Country (2016-2027)
Figure 50. Mexico Premature Labor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Premature Labor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Premature Labor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Premature Labor Treatment Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Premature Labor Treatment Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Premature Labor Treatment Market Share by Country (2016-2027)
Figure 56. Turkey Premature Labor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Premature Labor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Premature Labor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. AMAG Pharmaceuticals Inc Revenue Growth Rate in Premature Labor Treatment Business (2016-2021)
Figure 60. GlaxoSmithKline Plc Revenue Growth Rate in Premature Labor Treatment Business (2016-2021)
Figure 61. Juniper Pharmaceuticals Inc Revenue Growth Rate in Premature Labor Treatment Business (2016-2021)
Figure 62. Kissei Pharmaceutical Co Ltd Revenue Growth Rate in Premature Labor Treatment Business (2016-2021)
Figure 63. Lipocine Inc Revenue Growth Rate in Premature Labor Treatment Business (2016-2021)
Figure 64. ObsEva SA Revenue Growth Rate in Premature Labor Treatment Business (2016-2021)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed

以下、関連資料のご紹介

世界の早漏治療市場規模・現状・予測（2021年-2027年）

Global Premature Ejaculation Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z4768 2021年4月 93Pages
QYResearch社発行の本調査資料では、早漏治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（シアリス、バイアグラ、レビトラ）、用途別市場規模（スーパー、病院、薬局、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、...

世界の早期陣痛治療市場規模・現状・予測（2021年-2027年）

Global Preterm Labor Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z4784 2021年4月 96Pages
QYResearch社発行の本調査資料では、早期陣痛治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（子宮収縮抑制薬、ベータ模倣薬、カルシウムチャネル遮断薬、NSAID、コルチコステロイド、硫酸マグネシウム、抗生物質）、用途別市場規模（病院、...

世界の前期破水（PROM）検査市場規模・現状・予測（2021年-2027年）

Global Premature Rupture of Membranes (PROM) Testing Market Size, Status and Forecast 2021-2027
QYR2104Z4770 2021年4月 90Pages
QYResearch社発行の本調査資料では、前期破水（PROM）検査のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ニトラジン/pH検査、シダ状結晶形成検査、アニシュア検査、その他）、用途別市場規模（病院、診療所、診断研究所、その他）、主要地域...

世界の後天性血友病A治療市場規模・現状・予測（2021年-2027年）

Global Acquired hemophilia A Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z0029 2021年4月 97Pages
QYResearch社発行の本調査資料では、後天性血友病A治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（200IU、250IU）、用途別市場規模（病院、薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、イン...

世界のスウェーデンポルフィリン症治療市場規模・現状・予測（2021年-2027年）

Global Swedish Porphyria Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z5520 2021年4月 99Pages
QYResearch社発行の本調査資料では、スウェーデンポルフィリン症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（350mg、313mg）、用途別市場規模（病院、薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国...

世界の急性間欠性ポルフィリン症（AIP）治療市場規模・現状・予測（2021年-2027年）

Global Acute Intermittent Porphyria Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z0060 2021年4月 92Pages
QYResearch社発行の本調査資料では、急性間欠性ポルフィリン症（AIP）治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（350mg、313mg）、用途別市場規模（病院、薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日...

世界のアデノシンデアミナーゼ欠損症（ADA）治療市場規模・現状・予測（2021年-2027年）

Global Adenosine Deaminase Deficiency Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z0096 2021年4月 96Pages
QYResearch社発行の本調査資料では、アデノシンデアミナーゼ欠損症（ADA）治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（アダーゲン、レブコビ）、用途別市場規模（病院、薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、...

世界のMSD治療市場規模・現状・予測（2021年-2027年）

Global MSD Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z3939 2021年4月 91Pages
QYResearch社発行の本調査資料では、MSD治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（OTC、Rx薬）、用途別市場規模（病院、小売薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジ...

世界の軟骨無形成症治療市場規模・現状・予測（2021年-2027年）

Global Achondroplasia Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z0013 2021年4月 92Pages
QYResearch社発行の本調査資料では、軟骨無形成症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（RBM-007、TA-46、B-701、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、ヨーロ...

世界の神経芽細胞腫治療市場規模・現状・予測（2021年-2027年）

Global Neuroblastoma Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z4085 2021年4月 90Pages
QYResearch社発行の本調査資料では、神経芽細胞腫治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（併用化学療法、モノクローナル抗体療法、ワクチン療法、その他）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ...

世界の早漏治療市場規模・現状・予測（2021年-2027年） Premature ejaculation is one of the most common sexual dysfunctions occurring in men. A major reason for the market growth in the Americas is a significant rise in the number of premature ejaculation patients due to psychological factors such as strain and stress resulting from the ever-changing lif…
世界の早期陣痛治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Preterm Labor Treatment Market The global Preterm Labor Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the re…
世界の前期破水（PROM）検査市場規模・現状・予測（2021年-2027年） The premature rupture of membranes (PROM) is a condition that occurs in pregnancy. It is defined as the breakage of the amniotic sac, which generally takes place one or two hours before the onset of contractions or labor. The early breakage of the membrane, i.e. before 37 weeks of gestation, can lea…
世界の胎児（陣痛＆分娩）・新生児ケア用機器市場 2021：企業別、地域別、種類・用途別 The Fetal (Labor & Delivery) And Neonatal Care Equipment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chai…
世界の網膜芽細胞腫治療市場規模・現状・予測（2021年-2027年） Retinoblastoma is a cancer that starts in the retina, the very back part of the eye. Market Analysis and Insights: Global Retinoblastoma Treatment Market The global Retinoblastoma Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during…